This is an application for a K23- Mentored Patient-Oriented Research Career Development Award entitled: Proteomic Studies of MMP Profiles in Stroke Thrombolysis. The candidate proposes to use proteomic technology to investigate the mechanism of matrix metallo-proteinases (MMPs) in thrombolysis outcome of acute cerebral focal ischemia, with the ultimate goal of optimizing patient selection to make acute stroke treatment safer and more utilized. We hypothesize that MMP-9 contributes to tPA-related injuries by triggering important downstream cell-cell and cell-matrix signaling mechanisms. The primary goals of the proposed research are: 1) to investigate MMP-9's potential downstream substrates in human endothelial cell culture over-expressing MMP-9;2) to expand MMP-9 substrate characterization to the more complex but more physiologically-relevant environment of thrombolysed human plasma, thereby identifying additional substrates of MMP-9 and of other important candidate proteases;and 3) to conduct exploratory studies to expand the repertoire of proteases important to thrombolysis outcome, as potential targets for therapy. The candidate seeks training in: 1) proteomic techniques and the basic principles of bioinformatics, to analyze proteomic data in human samples and cell cultures;2) the neurobiology of thrombolysis-related adverse outcome in focal ischemia;3) advanced epidemiological clinical research methods, to further patient-oriented research. The proposed research plan, didactic courses, and tutorial instructions from mentors and advisors will ensure the career development of the candidate into an independent clinician scientist.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23NS051588-05
Application #
7628027
Study Section
NST-2 Subcommittee (NST)
Program Officer
Jacobs, Tom P
Project Start
2005-07-29
Project End
2011-05-31
Budget Start
2009-06-01
Budget End
2011-05-31
Support Year
5
Fiscal Year
2009
Total Cost
$172,440
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Deng, Wenjun; Cao, Jing; Chen, Lei et al. (2018) Plasma Glycoproteomic Study of Therapeutic Hypothermia Reveals Novel Markers Predicting Neurologic Outcome Post-cardiac Arrest. Transl Stroke Res 9:64-73
Ning, Mingming; Sarracino, David A; Kho, Alvin T et al. (2011) Proteomic temporal profile of human brain endothelium after oxidative stress. Stroke 42:37-43
Chou, Sherry H-Y; Lee, Po-Shun; Konigsberg, Rachael G et al. (2011) Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage. Stroke 42:3624-7
Ning, Mingming; Sarracino, David A; Buonanno, Ferdinando S et al. (2010) Proteomic Protease Substrate Profiling of tPA Treatment in Acute Ischemic Stroke Patients: A Step Toward Individualizing Thrombolytic Therapy at the Bedside. Transl Stroke Res 1:268-275
Ning, Mingming; Lo, Eng H (2010) Opportunities and Challenges in Omics. Transl Stroke Res 1:233-237
Xing, Changhong; Lee, Sunryung; Kim, Woo Jean et al. (2009) Neurovascular effects of CD47 signaling: promotion of cell death, inflammation, and suppression of angiogenesis in brain endothelial cells in vitro. J Neurosci Res 87:2571-7
Ning, Mingming; Wang, Xiaoying; Lo, Eng H (2009) Reperfusion injury after stroke: neurovascular proteases and the blood-brain barrier. Handb Clin Neurol 92:117-36
Kiernan, Thomas J; Yan, Bryan P; Cubeddu, Roberto J et al. (2009) May-Thurner syndrome in patients with cryptogenic stroke and patent foramen ovale: an important clinical association. Stroke 40:1502-4
Kelly, Peter J; Morrow, Jason D; Ning, MingMing et al. (2008) Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 39:100-4
Ng, Yee Sien; Stein, Joel; Ning, Mingming et al. (2007) Comparison of clinical characteristics and functional outcomes of ischemic stroke in different vascular territories. Stroke 38:2309-14